Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Chronic myelogenous leukemia].
Hochhaus A, La Rosée P, Eigendorff E, Ernst T. Hochhaus A, et al. Among authors: eigendorff e. Internist (Berl). 2015 Apr;56(4):333-43. doi: 10.1007/s00108-014-3594-7. Internist (Berl). 2015. PMID: 25860113 German.
[Chronic Myelogenous Leukemia].
Hochhaus A, Eigendorff E, Ernst T. Hochhaus A, et al. Among authors: eigendorff e. Dtsch Med Wochenschr. 2018 Sep;143(18):1304-1310. doi: 10.1055/s-0043-121023. Epub 2018 Sep 10. Dtsch Med Wochenschr. 2018. PMID: 30199910 German.
[Acute leukemia in adults].
Eigendorff E, Hochhaus A. Eigendorff E, et al. Pathologe. 2015 Sep;36(5):503-17; quiz 518-9. doi: 10.1007/s00292-015-0087-y. Pathologe. 2015. PMID: 26314268 Review. German.
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
Schütz C, Inselmann S, Saussele S, Dietz CT, Mu Ller MC, Eigendorff E, Brendel CA, Metzelder SK, Bru Mmendorf TH, Waller C, Dengler J, Goebeler ME, Herbst R, Freunek G, Hanzel S, Illmer T, Wang Y, Lange T, Finkernagel F, Hehlmann R, Huber M, Neubauer A, Hochhaus A, Guilhot J, Xavier Mahon F, Pfirrmann M, Burchert A. Schütz C, et al. Among authors: eigendorff e. Leukemia. 2017 Apr;31(4):829-836. doi: 10.1038/leu.2017.9. Epub 2017 Jan 11. Leukemia. 2017. PMID: 28074067
Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CML.
Schütz C, Inselmann S, Saussele S, Dietz CT, Müller MC, Eigendorff E, Brendel CA, Metzelder SK, Brümmendorf TH, Waller C, Dengler J, Goebeler ME, Herbst R, Freunek G, Hanzel S, Illmer T, Wang Y, Lange T, Finkernagel F, Hehlmann R, Huber M, Neubauer A, Hochhaus A, Guilhot J, Mahon FX, Pfirrmann M, Burchert A. Schütz C, et al. Among authors: eigendorff e. Leukemia. 2018 Apr;32(4):1054. doi: 10.1038/leu.2017.348. Epub 2018 Jan 30. Leukemia. 2018. PMID: 29381150
Cost-effectiveness of Tyrosine Kinase Inhibitor Treatment Strategies for Chronic Myeloid Leukemia in Chronic Phase After Generic Entry of Imatinib in the United States.
Padula WV, Larson RA, Dusetzina SB, Apperley JF, Hehlmann R, Baccarani M, Eigendorff E, Guilhot J, Guilhot F, Hehlmann R, Mahon FX, Martinelli G, Mayer J, Müller MC, Niederwieser D, Saussele S, Schiffer CA, Silver RT, Simonsson B, Conti RM. Padula WV, et al. Among authors: eigendorff e. J Natl Cancer Inst. 2016 Mar 4;108(7):djw003. doi: 10.1093/jnci/djw003. Print 2016 Jul. J Natl Cancer Inst. 2016. PMID: 26944912 Free PMC article.
Efficacy of Pazopanib With or Without Gemcitabine in Patients With Anthracycline- and/or Ifosfamide-Refractory Soft Tissue Sarcoma: Final Results of the PAPAGEMO Phase 2 Randomized Clinical Trial.
Schmoll HJ, Lindner LH, Reichardt P, Heißner K, Kopp HG, Kessler T, Mayer-Steinacker R, Rüssel J, Egerer G, Crysandt M, Kasper B, Niederwieser D, Kunitz A, Eigendorff E, Petersen I, Steighardt J, Cygon F, Meinert F, Stein A. Schmoll HJ, et al. Among authors: eigendorff e. JAMA Oncol. 2021 Feb 1;7(2):255-262. doi: 10.1001/jamaoncol.2020.6564. JAMA Oncol. 2021. PMID: 33355646 Free PMC article. Clinical Trial.
22 results